Lixiaoling
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors (NCT07387874) | Lixiaoling | 2025-07-10 |
Track Lixiaoling automatically
Every clearance here is in the API, with alerts when new ones post.